A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers

Abstract Background While high-grade serous ovarian cancer (HGSC) has proven largely resistant to immunotherapy, sporadic incidents of partial and complete response have been observed in clinical trials and case reports. These observations suggest that a molecular basis for effective immunity may ex...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laurel K. Berry, Ashok K. Pullikuth, Kristen L. Stearns, Yuezhu Wang, Calvin J. Wagner, Jeff W. Chou, Janelle P. Darby, Michael G. Kelly, Raghvendra Mall, Ming Leung, Julia Chifman, Lance D. Miller
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Subjects:	High grade serous ovarian cancer Immunogenicity Immune activation Immunosuppression Immune evasion Mutational burden
Online Access:	https://doi.org/10.1186/s12967-024-05846-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Examining the evidence for immune checkpoint therapy in high-grade serous ovarian cancer
by: A.E. Connor, et al.
Published: (2024-10-01)

Effects of virus-induced immunogenic cues on oncolytic virotherapy
by: Darshak K. Bhatt, et al.
Published: (2024-11-01)

Primary pleural serous carcinoma of mullerian origin—Report of a rare case
by: Shilpi Modi, et al.
Published: (2024-12-01)

Cytopathologic Diagnosis of Serous Fluids /
by: Shidham, Vinod B
Published: (2007)

A Rare Case of Deep Pelvic Endometriosis Presenting with Serous Ascites and Infertility
by: Türkan Gürsu, et al.
Published: (2015-08-01)

M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance
by: Naisheng Zheng, et al.
Published: (2023-12-01)

Sequential Serous Choroidal Detachment in Subjects Undergoing Bilateral Trabeculectomy
by: Maryam Yadgari, et al.
Published: (2024-12-01)

Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial
by: Siyue Jia, et al.
Published: (2025-12-01)

Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10–60 Years Age Group: A Follow-Up Report Based on Phase III Clinical Trial
by: Yunpeng Wang, et al.
Published: (2024-10-01)

Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies
by: Nicole L. Jarvi, et al.
Published: (2024-12-01)

Host Innate and Adaptive Immunity Against African Swine Fever Virus Infection
by: Tianqi Zhang, et al.
Published: (2024-11-01)

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
by: Cong Luo, et al.
Published: (2025-01-01)

Overcoming immune evasion with innovative multi-target approaches for glioblastoma
by: Hai Su, et al.
Published: (2025-01-01)

Research Hotspots and Trends in Global Cancer immunometabolism:A Bibliometric Analysis from 2000 to 2023
by: Chen S, et al.
Published: (2024-11-01)

Nanomedicine based on chemotherapy-induced immunogenic death combined with immunotherapy to enhance antitumor immunity
by: Yichang Chen, et al.
Published: (2024-12-01)

ClassifieR 2.0: expanding interactive gene expression-based stratification to prostate and high-grade serous ovarian cancer
by: Aideen McCabe, et al.
Published: (2024-11-01)

A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
by: Guojuan Sun, et al.
Published: (2025-01-01)

The landscape of immunogenic cell death-related genes predicts the overall survival and immune infiltration status of non-small-cell lung carcinoma
by: Jian Zhang, et al.
Published: (2025-01-01)

Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis
by: Min Hu, et al.
Published: (2025-01-01)

Modulating immune responses for enhanced cell therapies: The dual role of multi-scale biomaterials
by: Jia'nan Zeng, et al.
Published: (2024-12-01)

The nuclear localization signal of monkeypox virus protein P2 orthologue is critical for inhibition of IRF3-mediated innate immunity
by: Pengtao Jiao, et al.
Published: (2024-12-01)

The Effect of Dorzolamide Ophthalmic Drops in the Treatment of Patients with Central Serous Chorioretinopathy
by: R Ebrahimi, et al.
Published: (2024-03-01)

Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes
by: Joep MA Bogaerts, et al.
Published: (2024-11-01)

Immunogenicity and vaccine efficacy of Actinobacillus pleuropneumoniae-derived extracellular vesicles as a novel vaccine candidate
by: Su Hyun Park, et al.
Published: (2025-12-01)

Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors
by: Valeria Lombardi Fäh, et al.
Published: (2024-12-01)

Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer
by: Yan Wang, et al.
Published: (2024-12-01)

Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization
by: Umesh Chandra Behera, et al.
Published: (2025-01-01)

HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions
by: Dimitrios Papageorgiou, et al.
Published: (2024-12-01)

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion
by: Zheng Chen, et al.
Published: (2024-12-01)

From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape
by: Mengqian Jiang, et al.
Published: (2024-11-01)

Investigation of pharmacokinetics and immunogenicity of magnetosomes
by: M. Haripriyaa, et al.
Published: (2024-12-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic
by: Kun-Lin Lu, et al.
Published: (2024-11-01)

Trial watch: chemotherapy-induced immunogenic cell death in oncology
by: Jenny Sprooten, et al.
Published: (2023-12-01)

Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections
by: Dana Unninayar, et al.
Published: (2025-01-01)

Interplay of swine acute diarrhoea syndrome coronavirus and the host intrinsic and innate immunity
by: Fei Zhao, et al.
Published: (2025-01-01)

Micropulse Laser Therapy in Central Serous Chorioretinopathy
by: Flaviu Bodea, et al.
Published: (2024-11-01)

FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
by: Jian Chen, et al.
Published: (2025-01-01)

SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis
by: Laura Gebetsberger, et al.
Published: (2024-12-01)

Host–virus interactions during infection with a wild-type ILTV strain or a glycoprotein G deletion mutant ILTV vaccine strain in an ex vivo system
by: Gayathri Gopakumar, et al.
Published: (2025-02-01)